Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88130645 |
LAW OFFICE ASSIGNED |
LAW OFFICE 105 |
MARK SECTION |
MARK |
TIVDAK (see, http://uspto.report/TM/88130645/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
TIVDAK |
OWNER SECTION (current) |
NAME |
Seattle Genetics, Inc. |
MAILING ADDRESS |
21823 30th Drive S.E. |
CITY |
Bothell |
STATE |
Washington |
ZIP/POSTAL CODE |
98021 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Seattle Genetics, Inc. |
MAILING ADDRESS |
21823 30th Drive S.E. |
CITY |
Bothell |
STATE |
Washington |
ZIP/POSTAL CODE |
98021 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
John C. Baum |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
OWEN, WICKERSHAM & ERICKSON, P.C. |
STREET |
455 MARKET STREET, SUITE 1910 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94105 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-882-3200 |
FAX |
415-882-3232 |
EMAIL |
tmparalegal@owe.com |
DOCKET/REFERENCE NUMBER |
SEATTLE00025 |
ATTORNEY INFORMATION (proposed) |
NAME |
John C. Baum |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
OWEN, WICKERSHAM & ERICKSON, P.C. |
STREET |
455 MARKET STREET, SUITE 1910 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94105 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-882-3200 |
FAX |
415-882-3232 |
EMAIL |
tmparalegal@owe.com |
DOCKET/REFERENCE NUMBER |
SEATTLE00025 |
OTHER APPOINTED ATTORNEY |
Gregory N. Owen, Lawrence G. Townsend, Linda Joy Kattwinkel, Spencer F. Owen, and Erin M. Clarke |
CORRESPONDENCE INFORMATION (current) |
NAME |
JOHN C. BAUM |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmparalegal@owe.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
jcbaum@owe.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
John C. Baum |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmparalegal@owe.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
jcbaum@owe.com |
DOCKET/REFERENCE NUMBER |
SEATTLE00025 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions;
pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the
musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in
dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of
pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory
system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases,
inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
10/29/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/John C. Baum/ |
SIGNATORY'S NAME |
John C. Baum |
SIGNATORY'S POSITION |
Attorney of record, California Bar member |
DATE SIGNED |
04/03/2020 |
SIGNATORY'S PHONE NUMBER |
415-882-3200 |
FILING INFORMATION |
SUBMIT DATE |
Fri Apr 03 22:46:31 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XX.XX-20
200403224631145536-881306
45-71056eb4e917e552a72de2
9955453a1f2694e5afa9cd915
9aac75385e4ea32934-DA-463
01240-2020040322432045520
5 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TIVDAK (see, http://uspto.report/TM/88130645/mark.png)
SERIAL NUMBER: 88130645
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Seattle Genetics, Inc., having an address of
21823 30th Drive S.E.
Bothell, Washington 98021
United States
Proposed: Seattle Genetics, Inc., having an address of
21823 30th Drive S.E.
Bothell, Washington 98021
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/29/2019.
For International Class 005:
Current identification: Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for
the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the
genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology,
hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the
diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and
the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders,
gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
John C. Baum OWEN, WICKERSHAM & ERICKSON, P.C.
455 MARKET STREET, SUITE 1910
SAN FRANCISCO, California 94105
United States
Phone: 415-882-3200
Fax: 415-882-3232
The docket/reference number is SEATTLE00025
Email: tmparalegal@owe.com
The applicant's proposed Attorney Information:
John C. Baum OWEN, WICKERSHAM & ERICKSON, P.C.
455 MARKET STREET, SUITE 1910
SAN FRANCISCO, California 94105
United States
Phone: 415-882-3200
Fax: 415-882-3232
The docket/reference number is SEATTLE00025
Email: tmparalegal@owe.com
Correspondence Information (current):
JOHN C. BAUM
PRIMARY EMAIL FOR CORRESPONDENCE: tmparalegal@owe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jcbaum@owe.com
Correspondence Information (proposed):
John C. Baum
PRIMARY EMAIL FOR CORRESPONDENCE: tmparalegal@owe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jcbaum@owe.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /John C. Baum/ Date Signed: 04/03/2020
Signatory's Name: John C. Baum
Signatory's Position: Attorney of record, California Bar member
Signatory's Phone: 415-882-3200
Mailing Address:
OWEN, WICKERSHAM & ERICKSON, P.C.
455 MARKET STREET, SUITE 1910
SAN FRANCISCO, California 94105
RAM Sale Number: 88130645
RAM Accounting Date: 04/03/2020
Serial Number: 88130645
Internet Transmission Date: Fri Apr 03 22:46:31 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XX-20200403224631145
536-88130645-71056eb4e917e552a72de299554
53a1f2694e5afa9cd9159aac75385e4ea32934-D
A-46301240-20200403224320455205